FIELD: pharmaceuticals; medicine.
SUBSTANCE: first object is a pharmaceutical composition for the treatment or prevention of onychomycosis, containing luliconazole or its pharmaceutically acceptable salt as an active ingredient, and the pharmaceutical composition contains, relative to the total weight of the pharmaceutical composition: from 5 to 12% by weight of luliconazole or its pharmaceutically acceptable salt; 5 to 40% by weight of polyethylene glycol having an average molecular weight of 380 to 420, corresponding to the formula HOCH2(CH2OCH2)nCH2OH, where n is an integer; from 20% to 70% by weight of ethanol; from 0.01 to 10% by weight of benzyl alcohol; from 1 to 10% by weight of lactic acid; from 1 to 15% by weight of propylene carbonate and from 3 to 10% by weight of acetone. The second object is a method of obtaining a pharmaceutical composition. The third object is the use of a pharmaceutical composition for the treatment or prevention of onychomycosis.
EFFECT: stability of a pharmaceutical composition for external use containing luliconazole.
23 cl, 5 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
TOPICAL PHARMACEUTICAL COMPOSITIONS OF LULICONAZOLE | 2022 |
|
RU2823711C2 |
PHARMACEUTICAL COMPOSITION FOR EXTERNAL APPLICATION | 2006 |
|
RU2419429C2 |
PHARMACEUTIC COMPOSITION FOR EXTERNAL APPLICATION | 2006 |
|
RU2415669C2 |
PHARMACEUTICAL COMPOSITION COMPRISING LULICONAZOLE | 2013 |
|
RU2621615C2 |
AMIDE DERIVATIVE AND USE OF SAME AS STABILITY INDEX OF A LULICONAZOLE PHARMACEUTICAL FORMULATION | 2013 |
|
RU2612557C2 |
CRYSTAL HAVING CRYSTAL HABIT, AND PHARMACEUTICAL COMPOSITION PREPARED BY TREATMENT OF SAID CRYSTAL | 2012 |
|
RU2603963C2 |
ANTIMYCOTIC NAIL COATING AND METHOD OF APPLICATION THEREOF | 2004 |
|
RU2358718C2 |
CRYSTALLINE SUBSTANCE AND PHARMACEUTICAL PREPARATION CONTAINING IT | 2013 |
|
RU2622644C2 |
WATER-AND-ALCOHOL SYSTEM FOR NAIL TREATMENT | 2015 |
|
RU2730010C2 |
PHARMACEUTICAL COMPOSITION SHOWING ANTIFUNGAL EFFECT | 1992 |
|
RU2110257C1 |
Authors
Dates
2023-07-04—Published
2020-08-07—Filed